ArticleStem cells international2026
Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma.
Yang Zi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.